On ECHEMI
Home > Drugs > Glycogen storage disease type IX
Glycogen storage disease type IX
Glycogen storage disease (GSD) is a type of glycogen metabolism disorder caused by congenital enzyme defects. Glycogen storage disease type IX (GSD-IX) is a group of different diseases caused by the lack of phosphorylase kinase and is a hereditary disease. It includes X-linked hereditary liver phosphorylase kinase deficiency, autosomal hereditary liver and muscle phosphorylase kinase deficiency, specific muscle phosphorylase kinase deficiency and cardiac phosphorylase kinase deficiency.
  • Site of disease:

    whole body
  • Infectious :

    Not contagious
  • Frequent population:

    child
  • Related symptoms:

    Muscle atrophy Enlarged liver Slow growth Enlarged liver Loss of muscle tone
Related Drugs
Compound Allopurinol Tablets
Indication: Used for 1. Primary and secondary hyperuricemia, especially hyperuricemia caused by excessive uric acid production; 2. Patients with recurrent or chronic gout; 3. Tophi; 4. Uric acid kidney stones and (or) uric acid nephropathy; 5. Hyperuricemia with renal insufficiency.
Manufacturer:

Guangdong Shixin Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.